Results 111 to 120 of about 41,447 (182)

Bilateral intracochlear hemorrhage: A rare onset of chronic myelogenous leukemia. [PDF]

Clin Case Rep
Flahat B, Bonnard Å, Arebro J.
europepmc   +1 more source

Living with chronic myelogenous leukemia in rural communities: Exploring factors related to tyrosine kinase inhibitors adherence with a mixed methods approach. [PDF]

J Rural Health
Sheng J, Heiney SP, Wickersham KE, Nguyen LA, Harrison KW, Adams SA.   +5 more
europepmc   +1 more source

Successful treatment of myeloid blast phase chronic myelogenous leukemia with the JAK2 V617 F mutation by combination therapy with asciminib and ropeginterferon alfa-2b in an elderly patient. [PDF]

Int J Hematol
Oka S, Akagi Y, Mituyoshi T, Ono K.
europepmc   +1 more source

CDK8/19 inhibition attenuates G1 arrest induced by BCR-ABL antagonists and accelerates death of chronic myelogenous leukemia cells. [PDF]

Cell Death Discov
Khamidullina AI, Yastrebova MA, Bruter AV, Nuzhina JV, Vorobyeva NE, Khrustaleva AM, Varlamova EA, Tyakht AV, Abramenko IE, Ivanova ES, Zamkova MA, Li J, Lim CU, Chen M, Broude EV, Roninson IB, Shtil AA, Tatarskiy VV.   +17 more
europepmc   +1 more source

Chronic myelogenous leukemia coexpressing V-e16a2, V-e13a2, e13a2, and e14a2 BCR::ABL1 fusion transcripts: a case report and review of the literature. [PDF]

Front Oncol
Xu Y, Fan Y, Liu S, Chang J, Guo C, Chen L, Guo W, Dang J, Wang H, Tan Y.   +9 more
europepmc   +1 more source

Extracellular vesicles enhance the in vivo antitumor effects of millettia species-derived compounds in chronic myelogenous leukemia therapy. [PDF]

Front Chem
Xie Z, Cheng X, Mao J, Zhu Y, Li L, Mei Z.   +5 more
europepmc   +1 more source

Enabling biomedical technologies for chronic myelogenous leukemia (CML) biomarkers detection. [PDF]

Biomicrofluidics
Pinnenti M, Sami MA, Hassan U.
europepmc   +1 more source

Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib. [PDF]

Sci Rep
Klaihmon P, Lorthongpanich C, Kheolamai P, Saisaard W, Issaragrisil S.   +4 more
europepmc   +1 more source

Association of Nilotinib With Cardiovascular Diseases in Patients With Chronic Myelogenous Leukemia: A National Population-Based Cohort Study. [PDF]

Oncologist
Huang CE, Lee KD, Chang JJ, Tzeng HE, Huang SH, Yu LH, Chen MC.   +6 more
europepmc   +1 more source